Yelin Jun News Today

GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A....

YONGIN, South Korea, May 7, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical

/PRNewswire/ -- GC Biopharma Corp. (006280.KS) announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its...

/PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous,...

/PRNewswire/ -- GC Biopharma (006280.KS), a South Korean biopharmaceutical company (CEO, Eun-Chul Huh), announced on November 30th that it has completed the...

/PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, announced on November 20th that it has been selected as the Top 10 Bioanalytical...

Brining Expertise in NK Cell Therapy to Advance Efforts in Cancer Prevention, early detection, and treatment development ▶ New focus on NK cell therapy for...

/PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present data showcasing deep learning algorithm utilizing...

YONGIN, South Korea, Oct. 10, 2023 /PRNewswire/ -- GC Biopharma Corp. announced today that it has presented the successful adoption of SAP Success...

YONGIN, South Korea, Oct. 10, 2023 /PRNewswire/ -- GC Biopharma Corp. announced on today that it has signed Power Purchase Agreement (PPA) with SK...